Forteo 560 MCG/2.24 ML pen INJ 2.24ML
Ended Awarded Last action
- Contract number
- SPE2DR26F21GF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $71,208
Award facts
- Contract value 100% obligated
- $71,207.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $71,207.73 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) on January 26, 2026, with completion scheduled for January 27, 2026. This competitive award, which includes no set-aside designation, was issued under a firm fixed-price structure and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order execution under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Forteo is an FDA-approved prescription medication used in the treatment of osteoporosis and bone health conditions, representing part of the pharmaceutical and medical supply chain that DLA maintains to support military treatment facilities and veterans' healthcare programs. AmerisourceBergen's established role as a primary vendor for federal pharmaceutical procurement, combined with its significant IDC authority, enables efficient fulfillment of time-sensitive medical supply needs across the Defense Health Agency and other government healthcare systems. This delivery order exemplifies the operational execution of the broader pharmaceutical prime vendor relationship between DLA and AmerisourceBergen for medical commodities required by federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26F21GF?
SPE2DR26F21GF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F21GF worth?
The government has obligated $71,208 on SPE2DR26F21GF.
Is contract SPE2DR26F21GF an order under another contract?
Yes. SPE2DR26F21GF is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F21GF competed?
The extent of competition for SPE2DR26F21GF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award